Significant technological and scientific development over the last few years has shown that the EU’s framework on blood, tissues and...
Cortex - Life Sciences Insights
At a time when the importance of the life sciences industry to our daily lives has never been clearer, the UK Government has been...
In response to a set of questions from the European Commission, the European Data Protection Board (“EDPB”) has published some high level...
Portugal published Law no. 4-C/2021, which transposes the Directive (EU) 2020/2020 from the 7th of December 2020, as regards temporary...
On 11 February 2021, the Department of Health and Social Care published a white paper - Integration and innovation: working together to...
The European Commission has published a guidance document aiming to further assist manufacturers with understanding how Legacy Devices...
The Australian Pharmaceutical Benefits Advisory Committee (PBAC) has amended its process for reviewing positive PBAC recommendations that...
In the recent past, sustainability, environmental, social and governance (SESG) issues took center stage in global business. In distinct...
The Australian Therapeutic Goods Administration (TGA) is currently conducting a public consultation into the “repurposing” of...
At a time where drug makers are taking action to develop modified versions of their vaccines in order to address the evolving variants of...
Cannabis remains a controlled substance in most jurisdictions, but demand for medicinal and wellbeing cannabis products and their...
The European Commission has accepted commitments by Aspen to reduce the price of six critical, off-patent, cancer medicines by 73% on...
Romania is one step closer to regulating telemedicine, as the draft general legal framework is now open to public debate ahead of its...
When the Covid-19 pandemic hit Europe in 2020, the Portuguese Government took the opportunity to establish the health sector as a...
This week I was kindly asked by Prohibition Partners - a leading consultancy focused on the global cannabis industry, to be interviewed...
In this month's 'Russia Pharmaceuticals Sector Update', Julien Hansen, Elena Mikhailovskaia and Pavel Arievich of DLA Piper's Moscow...
